Cellectar Biosciences, Inc. Convertible Debt
Cellectar Biosciences, Inc. (CLRB) had Convertible Debt of $4.00 million as of 2014-02-06, per its 10-K/A filed 2016-10-20.
Discontinued › Balance Sheet › Liabilities › Debt › Long-Term Debt, Unclassified
us-gaap:ConvertibleDebt · last filed 2016-10-20
- 2014-02-06: Convertible Debt $4.00M.
- 2014-02-05: Convertible Debt $4.00M.
| Period end | Convertible Debt |
|---|---|
| 2014-02-06 | $4.00M 10-K/A · filed 2016-10-20 |
| 2014-02-05 | $4.00M 10-Q · filed 2015-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |